NCT00366626View on ClinicalTrials.gov

Effectiveness of Naltrexone Versus Placebo to Reduce Craving for Alcohol With Evaluation of Genetic Variability.

PHASE4CompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Alcohol Dependence
Interventions
DRUG

Naltrexone

Naltrexone (25 mg/day for days 1-2 and 50 mg/day for days 3-7)

DRUG

Placebo

Placebo for 7 days matched to Naltrexone

Trial Locations (1)

29425

· Center for Drug and Alcohol Programs,· Medical University of South Carolina, Charleston

All Listed Sponsors
lead

Medical University of South Carolina

OTHER

NCT00366626 - Effectiveness of Naltrexone Versus Placebo to Reduce Craving for Alcohol With Evaluation of Genetic Variability. | Biotech Hunter | Biotech Hunter